文献速递胸部肿瘤

PD-1/C5a联合阻断协同保护对抗肺癌生长与转移

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis.
PubMed 文献 · Cancer Discov · 2017-03-13

在肺癌同种移植模型中,使用RMP1-14抗体阻断PD-1、L-适配体抑制C5a与其受体信号,联合C5a和PD-1阻断可显著减少肿瘤生长和转移并延长生存,伴随肿瘤内CD8 T细胞频率与髓源性抑制细胞频率呈负相关,可能更完全逆转CD8 T细胞耗竭,为抗PD-1与抗C5a联合治疗策略提供临床评价支持。

要点

  • 联合C5a和PD-1阻断可显著减少肺癌同种移植模型的肿瘤生长和转移并延长生存。
  • 该效应伴随肿瘤内CD8 T细胞频率与髓源性抑制细胞频率呈负相关。
  • 研究为抗PD-1与抗C5a药物联合治疗肺癌的临床评价提供依据。

核心结论

  • 联合阻断C5a可大幅提高抗PD-1抗体对抗肺癌生长和转移的疗效,为联合阻断PD-1/PD-L1与C5a恢复抗肿瘤免疫应答提供临床前依据。

研究设计与样本

  • 研究使用肺癌同种移植模型,以RMP1-14抗体阻断PD-1,以L-适配体抑制补体C5a与其受体的信号。

主要发现

  • 联合C5a和PD-1阻断显著减少肿瘤生长和转移并导致生存延长。
  • 该效应伴随肿瘤内CD8 T细胞频率与髓源性抑制细胞频率呈负相关,可能更完全逆转CD8 T细胞耗竭。

临床怎么用

  • 作者认为研究为抗PD-1与抗C5a药物作为肺癌新型联合治疗策略的临床评价提供支持。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Disruption of the programmed cell death protein 1 (PD-1) pathway with immune checkpoint inhibitors represents a major breakthrough in the treatment of non-small cell lung cancer. We hypothesized that combined inhibition of C5a/C5aR1 and PD-1 signaling may have a synergistic antitumor effect. The RMP1-14 antibody was used to block PD-1, and an L-aptamer was used to inhibit signaling of complement C5a with its receptors. Using syngeneic models of lung cancer, we demonstrate that the combination of C5a and PD-1 blockade markedly reduces tumor growth and metastasis and leads to prolonged survival. This effect is accompanied by a negative association between the frequency of CD8 T cells and myeloid-derived suppressor cells within tumors, which may result in a more complete reversal of CD8 T-cell exhaustion. Our study provides support for the clinical evaluation of anti-PD-1 and anti-C5a drugs as a novel combination therapeutic strategy for lung cancer.Significance: Using a variety of preclinical models of lung cancer, we demonstrate that the blockade of C5a results in a substantial improvement in the efficacy of anti-PD-1 antibodies against lung cancer growth and metastasis. This study provides the preclinical rationale for the combined blockade of PD-1/PD-L1 and C5a to restore antitumor immune responses, inhibit tumor cell growth, and improve outcomes of patients with lung cancer. Cancer Discov; 7(7); 694-703. ©2017 AACR.This article is highlighted in the In This Issue feature, p. 653.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Ajona D, Ortiz-Espinosa S, Moreno H, et al. A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis. Cancer Discov. 2017. PMID: 28288993. doi:10.1158/2159-8290.CD-16-1184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。